Int J Stem Cells.  2020 Mar;13(1):1-12. 10.15283/ijsc19127.

Hematopoietic Stem Cells and Their Roles in Tissue Regeneration

• Lee JY
• Hong SH

• KMID: 2500562
• DOI: http://doi.org/10.15283/ijsc19127

Abstract

Hematopoietic stem cells (HSCs) are regarded as one of essential cell sources for treating regenerative diseases. Among many stem cells, the feasibility of using adult-derived hematopoietic stem cells in therapeutic approaches is very diverse, and is unarguably regarded as an important cell source in stem cell biology. So far, many investigators are exploring HSCs and modified HSCs for use in clinical and basic science. In the present review, we briefly summarized HSCs and their application in pathophysiologic conditions, including non-hematopoietic tissue regeneration as well as blood disorders. HSCs and HSCs-derived progenitors are promising cell sources in regenerative medicine and their contributions can be properly applied to treat pathophysiologic conditions. Among many adult stem cells, HSCs are a powerful tool to treat patients with diseases such as hematologic malignancies and liver disease. Since HSCs can be differentiated into diverse progenitors including endothelial progenitors, they may be useful for constructing strategies for effective therapy.

Keyword

Hematopoietic stem cells; Stem cell therapy; Hematologic disorder; Liver disease

Figure

• 

  Fig. 1 Schematic illustration showed hematopoiesis in adult BM. HSCs have self-renewal activity and differentiation capability into blood cell lineages. LT-HSCs are quiescent and sustained by arrested cell division in endosteal niche, whereas ST-HSCs are promptly differentiated into myeloid and lymphoid lineage cells in vascular niche, and then lineage cells exit into periphery.

Reference

References

1. Till JE, Mcculloch EA. 1961; A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 14:213–222. DOI: 10.2307/3570892. PMID: 13776896.

2. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT. 2000; Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 287:1804–1808. DOI: 10.1126/science.287.5459.1804. PMID: 10710306.

3. Zhao M, Perry JM, Marshall H, Venkatraman A, Qian P, He XC, Ahamed J, Li L. 2014; Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat Med. 20:1321–1326. DOI: 10.1038/nm.3706. PMID: 25326798.

4. Ye M, Zhang H, Amabile G, Yang H, Staber PB, Zhang P, Levantini E, Alberich-Jordà M, Zhang J, Kawasaki A, Tenen DG. 2013; C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol. 15:385–394. DOI: 10.1038/ncb2698. PMID: 23502316. PMCID: PMC3781213.

5. Seita J, Weissman IL. 2010; Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med. 2:640–653. DOI: 10.1002/wsbm.86. PMID: 20890962. PMCID: PMC2950323.

6. Morrison SJ, Weissman IL. 1994; The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1:661–673. DOI: 10.1016/1074-7613(94)90037-X. PMID: 7541305.

7. Mebius RE, Miyamoto T, Christensen J, Domen J, Cupedo T, Weissman IL, Akashi K. 2001; The fetal liver counterpart of adult common lymphoid progenitors gives rise to all lymphoid lineages, CD45＋CD4＋CD3-cells, as well as macrophages. J Immunol. 166:6593–6601. DOI: 10.4049/jimmunol.166.11.6593. PMID: 11359812.

8. Kim JY, Lee JY, Ha KS, Han ET, Park WS, Min CK, Hong SH. 2018; Perivascular cells and NADPH oxidase inhibition partially restore hyperglycemia-induced alterations in hematopoietic stem cell and myeloid-derived suppressor cell populations in the bone marrow. Int J Stem Cells. 12:63–72. DOI: 10.15283/ijsc18097. PMID: 30595009. PMCID: PMC6457702.

9. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. 1957; Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 257:491–496. DOI: 10.1056/NEJM195709122571102. PMID: 13464965.

10. Thomas ED, Lochte HL Jr, Cannon JH, Sahler OD, Ferrebee JW. 1959; Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest. 38:1709–1716. DOI: 10.1172/JCI103949. PMID: 13837954. PMCID: PMC444138.

11. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. 1996; The aging of hematopoietic stem cells. Nat Med. 2:1011–1016. DOI: 10.1038/nm0996-1011. PMID: 8782459.

12. Florian MC, Dörr K, Niebel A, Daria D, Schrezenmeier H, Rojewski M, Filippi MD, Hasenberg A, Gunzer M, Scharffetter-Kochanek K, Zheng Y, Geiger H. 2012; Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell. 10:520–530. DOI: 10.1016/j.stem.2012.04.007. PMID: 22560076. PMCID: PMC3348626.

13. Dorshkind K, Montecino-Rodriguez E, Signer RA. 2009; The ageing immune system: is it ever too old to become young again? Nat Rev Immunol. 9:57–62. DOI: 10.1038/nri2471. PMID: 19104499.

14. Linton PJ, Dorshkind K. 2004; Age-related changes in lymphocyte development and function. Nat Immunol. 5:133–139. DOI: 10.1038/ni1033. PMID: 14749784.

15. Sun D, Luo M, Jeong M, Rodriguez B, Xia Z, Hannah R, Wang H, Le T, Faull KF, Chen R, Gu H, Bock C, Meissner A, Göttgens B, Darlington GJ, Li W, Goodell MA. 2014; Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell. 14:673–688. DOI: 10.1016/j.stem.2014.03.002. PMID: 24792119. PMCID: PMC4070311.

16. Allsopp RC, Morin GB, Horner JW, DePinho R, Harley CB, Weissman IL. 2003; Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat Med. 9:369–371. DOI: 10.1038/nm0403-369. PMID: 12669037.

17. Mohrin M, Shin J, Liu Y, Brown K, Luo H, Xi Y, Haynes CM, Chen D. 2015; Stem cell aging. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science. 347:1374–1377. DOI: 10.1126/science.aaa2361. PMID: 25792330. PMCID: PMC4447312.

18. Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley K, Triche TJ Jr, Laird PW, Baty JD, Fulton LL, Fulton R, Heath SE, Kalicki-Veizer J, Kandoth C, Klco JM, Koboldt DC, Kanchi KL, Kulkarni S, Lamprecht TL, Larson DE, Lin L, Lu C, McLellan MD, McMichael JF, Payton J, Schmidt H, Spencer DH, Tomasson MH, Wallis JW, Wartman LD, Watson MA, Welch J, Wendl MC, Ally A, Balasundaram M, Birol I, Butterfield Y, Chiu R, Chu A, Chuah E, Chun HJ, Corbett R, Dhalla N, Guin R, He A, Hirst C, Hirst M, Holt RA, Jones S, Karsan A, Lee D, Li HI, Marra MA, Mayo M, Moore RA, Mungall K, Parker J, Pleasance E, Plettner P, Schein J, Stoll D, Swanson L, Tam A, Thiessen N, Varhol R, Wye N, Zhao Y, Gabriel S, Getz G, Sougnez C, Zou L, Leiserson MD, Vandin F, Wu HT, Applebaum F, Baylin SB, Akbani R, Broom BM, Chen K, Motter TC, Nguyen K, Weinstein JN, Zhang N, Ferguson ML, Adams C, Black A, Bowen J, Gastier-Foster J, Grossman T, Lichtenberg T, Wise L, Davidsen T, Demchok JA, Shaw KR, Sheth M, Sofia HJ, Yang L, Downing JR, Eley G. Cancer Genome Atlas Research Network. 2013; Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 368:2059–2074. DOI: 10.1056/NEJMoa1301689. PMID: 23634996. PMCID: PMC3767041.

19. Sharma S, Gurudutta G. 2016; Epigenetic regulation of hematopoietic stem cells. Int J Stem Cells. 9:36–43. DOI: 10.15283/ijsc.2016.9.1.36. PMID: 27426084. PMCID: PMC4961102.

20. Dimopoulos K, Gimsing P, Grønbæk K. 2014; The role of epigenetics in the biology of multiple myeloma. Blood Cancer J. 4:e207. DOI: 10.1038/bcj.2014.29. PMID: 24786391. PMCID: PMC4042299.

21. Kim MJ, Kim MH, Kim SA, Chang JS. 2008; Age-related deterioration of hematopoietic stem cells. Int J Stem Cells. 1:55–63. DOI: 10.15283/ijsc.2008.1.1.55. PMID: 24855509. PMCID: PMC4021776.

22. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, Schrier SL, Weissman IL. 2011; Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. 108:20012–20017. DOI: 10.1073/pnas.1116110108. PMID: 22123971. PMCID: PMC3250139.

23. Kuranda K, Vargaftig J, de la Rochere P, Dosquet C, Charron D, Bardin F, Tonnelle C, Bonnet D, Goodhardt M. 2011; Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell. 10:542–546. DOI: 10.1111/j.1474-9726.2011.00675.x. PMID: 21418508.

24. Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M, Baker KS, Fung H, Gurney JG, McGlave PB, Nademanee A, Ramsay NK, Stein A, Weisdorf DJ, Forman SJ. 2005; Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood. 105:4215–4222. DOI: 10.1182/blood-2005-01-0035. PMID: 15701723. PMCID: PMC1895040.

25. Ford CE, Hamerton JL, Barnes DW, Loutit JF. 1956; Cytological identification of radiation-chimaeras. Nature. 177:452–454. DOI: 10.1038/177452a0. PMID: 13309336.

26. Morstyn G, Nicola NA, Metcalf D. 1980; Purification of hemopoietic progenitor cells from human marrow using a fucose-binding lectin and cell sorting. Blood. 56:798–805. DOI: 10.1182/blood.V56.5.798.798. PMID: 7000205.

27. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R. 1996; A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. N Engl J Med. 335:91–97. DOI: 10.1056/NEJM199607113350204. PMID: 8649495.

28. Kanate AS, Kharfan-Dabaja MA, Hamadani M. 2012; Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphoma. Bone Marrow Res. 2012:897215. DOI: 10.1155/2012/897215. PMID: 23097707. PMCID: PMC3477524.

29. Boulad F, Wang X, Qu J, Taylor C, Ferro L, Karponi G, Bartido S, Giardina P, Heller G, Prockop SE, Maggio A, Sadelain M, Rivière I. 2014; Safe mobilization of CD34＋ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation. Blood. 123:1483–1486. DOI: 10.1182/blood-2013-06-507178. PMID: 24429337. PMCID: PMC3945860.

30. Lucarelli G, Isgrò A, Sodani P, Gaziev J. 2012; Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med. 2:a011825. DOI: 10.1101/cshperspect.a011825. PMID: 22553502. PMCID: PMC3331690.

31. Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, Baldoli C, Martino S, Calabria A, Canale S, Benedicenti F, Vallanti G, Biasco L, Leo S, Kabbara N, Zanetti G, Rizzo WB, Mehta NA, Cicalese MP, Casiraghi M, Boelens JJ, Del Carro U, Dow DJ, Schmidt M, Assanelli A, Neduva V, Di Serio C, Stupka E, Gardner J, von Kalle C, Bordignon C, Ciceri F, Rovelli A, Roncarolo MG, Aiuti A, Sessa M, Naldini L. 2013; Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 341:1233158. DOI: 10.1126/science.1233158. PMID: 23845948.

32. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. 1997; Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:964–967. DOI: 10.1126/science.275.5302.964. PMID: 9020076.

33. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. 2001; Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105:369–377. DOI: 10.1016/S0092-8674(01)00328-2. PMID: 11348593.

34. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M. 2000; Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 6:1229–1234. DOI: 10.1038/81326. PMID: 11062533.

35. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. 2002; Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2256–2259. DOI: 10.1126/science.1074807. PMID: 12215650.

36. Zaret KS, Grompe M. 2008; Generation and regeneration of cells of the liver and pancreas. Science. 322:1490–1494. DOI: 10.1126/science.1161431. PMID: 19056973. PMCID: PMC2641009.

37. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. 1999; Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 5:434–438. DOI: 10.1038/7434. PMID: 10202935.

38. Eglitis MA, Mezey E. 1997; Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A. 94:4080–4085. DOI: 10.1073/pnas.94.8.4080. PMID: 9108108. PMCID: PMC20571.

39. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. 1998; Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 279:1528–1530. DOI: 10.1126/science.279.5356.1528. PMID: 9488650.

40. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. 1999; Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 85:221–228. DOI: 10.1161/01.RES.85.3.221. PMID: 10436164.

41. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. 1999; Bone marrow as a potential source of hepatic oval cells. Science. 284:1168–1170. DOI: 10.1126/science.284.5417.1168. PMID: 10325227.

42. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. 2000; Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 290:1779–1782. DOI: 10.1126/science.290.5497.1779. PMID: 11099419.

43. Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, Novelli M, Prentice G, Williamson J, Wright NA. 2000; Hepatocytes from non-hepatic adult stem cells. Nature. 406:257. DOI: 10.1038/35018642. PMID: 10917519.

44. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. 2001; Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci. 938:221–229. discussion 229-230. DOI: 10.1111/j.1749-6632.2001.tb03592.x. PMID: 11458511.

45. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA. 2001; Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 107:1395–1402. DOI: 10.1172/JCI12150. PMID: 11390421. PMCID: PMC209322.

46. Körbling M, Katz RL, Khanna A, Ruifrok AC, Rondon G, Albitar M, Champlin RE, Estrov Z. 2002; Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 346:738–746. DOI: 10.1056/NEJMoa3461002. PMID: 11882729.

47. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, Hanley A, Scadova H, Qin G, Cha DH, Johnson KL, Aikawa R, Asahara T, Losordo DW. 2005; Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 115:326–338. DOI: 10.1172/JCI200522326. PMID: 15690083. PMCID: PMC546424.

48. Lee JY, Park C, Cho YP, Lee E, Kim H, Kim P, Yun SH, Yoon YS. 2010; Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Circulation. 122:1413–1425. DOI: 10.1161/CIRCULATIONAHA.110.941468. PMID: 20855662. PMCID: PMC2989430.

49. Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo H, Houser SR. 2013; Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res. 113:539–552. DOI: 10.1161/CIRCRESAHA.113.301202. PMID: 23801066. PMCID: PMC3822430.

50. Lee SG, Moon SH, Kim HJ, Lee JY, Park SJ, Chung HM, Ha TY, Song GW, Jung DH, Park H, Kwon TW, Cho YP. 2015; Bone marrow-derived progenitor cells in de novo liver regeneration in liver transplant. Liver Transpl. 21:1186–1194. DOI: 10.1002/lt.24099. PMID: 25761987.

51. Michalopoulos GK, DeFrances MC. 1997; Liver regeneration. Science. 276:60–66. DOI: 10.1126/science.276.5309.60. PMID: 9082986.

52. Kakinuma S, Nakauchi H, Watanabe M. 2009; Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease. J Gastroenterol. 44:167–172. DOI: 10.1007/s00535-008-2297-z. PMID: 19214659.

53. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. 1996; Presence of hematopoietic stem cells in the adult liver. Nat Med. 2:198–203. DOI: 10.1038/nm0296-198. PMID: 8574965.

54. Starzl TE. 2002; The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg. 195:587–610. DOI: 10.1016/S1072-7515(02)01498-9. PMID: 12437245. PMCID: PMC2993503.

55. Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM, Krause DS. 2000; Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 31:235–240. DOI: 10.1002/hep.510310135. PMID: 10613752.

56. Shimano K, Satake M, Okaya A, Kitanaka J, Kitanaka N, Takemura M, Sakagami M, Terada N, Tsujimura T. 2003; Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol. 163:3–9. DOI: 10.1016/S0002-9440(10)63624-3. PMID: 12819005. PMCID: PMC1868160.

57. Abkowitz JL. 2002; Can human hematopoietic stem cells become skin, gut, or liver cells? N Engl J Med. 346:770–772. DOI: 10.1056/NEJM200203073461012. PMID: 11882735.

58. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M. 2003; Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 422:897–901. DOI: 10.1038/nature01531. PMID: 12665832.

59. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I. 2006; Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 24:2292–2298. DOI: 10.1634/stemcells.2005-0542. PMID: 16778155.

60. Yannaki E, Anagnostopoulos A, Kapetanos D, Xagorari A, Iordanidis F, Batsis I, Kaloyannidis P, Athanasiou E, Dourvas G, Kitis G, Fassas A. 2006; Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol. 34:1583–1587. DOI: 10.1016/j.exphem.2006.06.012. PMID: 17046578.

61. Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F, Ottobrelli A, Abate ML, Marzano A, Rizzetto M, Tarella C. 2006; Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol. 45:13–19. DOI: 10.1016/j.jhep.2006.02.018. PMID: 16635534.

62. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, M'Hamdi H, Thalji T, Welsh JP, Marley SB, Davies J, Dazzi F, Marelli-Berg F, Tait P, Playford R, Jiao L, Jensen S, Nicholls JP, Ayav A, Nohandani M, Farzaneh F, Gaken J, Dodge R, Alison M, Apperley JF, Lechler R, Habib NA. 2006; Characterization and clinical application of human CD34＋ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 24:1822–1830. DOI: 10.1634/stemcells.2005-0629. PMID: 16556705.

63. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, Kazemi Ashtiani S, Malekzadeh R, Baharvand H. 2007; Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 13:3359–3363. DOI: 10.3748/wjg.v13.i24.3359. PMID: 17659676. PMCID: PMC4172717.

64. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, Oliveira SA, Braga EL, de Carvalho WA, Genser B, dos Santos RR, Lyra LG. 2007; Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol. 13:1067–1073. DOI: 10.3748/wjg.v13.i7.1067. PMID: 17373741. PMCID: PMC4146869.

65. Yan L, Han Y, Wang J, Liu J, Hong L, Fan D. 2007; Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol. 82:949–954. DOI: 10.1002/ajh.21030. PMID: 17724706.

66. Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J, Rao SG, Narusu ML, Khaja MN, Pramila R, Habeeb A, Habibullah CM. 2008; Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc. 40:1140–1144. DOI: 10.1016/j.transproceed.2008.03.111. PMID: 18555134.

67. Levicar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, Davis J, Dazzi F, Smadja C, Jensen SL, Nicholls JP, Apperley JF, Gordon MY. 2008; Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34＋ cells in patients with chronic liver disease. Cell Prolif. 41(Suppl 1):115–125. DOI: 10.1111/j.1365-2184.2008.00491.x. PMID: 18181952. PMCID: PMC6496663.

68. Han Y, Yan L, Han G, Zhou X, Hong L, Yin Z, Zhang X, Wang S, Wang J, Sun A, Liu Z, Xie H, Wu K, Ding J, Fan D. 2008; Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy. 10:390–396. DOI: 10.1080/14653240802129901. PMID: 18574771.

69. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levicar N, Tait P, Scott M, Marley SB, Jestice K, Glibetic M, Bansi D, Khan SA, Kyriakou D, Rountas C, Thillainayagam A, Nicholls JP, Jensen S, Apperley JF, Gordon MY, Habib NA. 2008; Autologous infusion of expanded mobilized adult bone marrow-derived CD34＋ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 103:1952–1958. DOI: 10.1111/j.1572-0241.2008.01993.x. PMID: 18637092.

70. Salama H, Zekri AR, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, Mohamed G, Al Alim SA, Sherif GM. 2010; Autologous CD34＋ and CD133＋ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol. 16:5297–5305. DOI: 10.3748/wjg.v16.i42.5297. PMID: 21072892. PMCID: PMC2980678.

71. Kim JK, Park YN, Kim JS, Park MS, Paik YH, Seok JY, Chung YE, Kim HO, Kim KS, Ahn SH, Kim DY, Kim MJ, Lee KS, Chon CY, Kim SJ, Terai S, Sakaida I, Han KH. 2010; Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant. 19:1237–1246. DOI: 10.3727/096368910X506863. PMID: 20525430.

72. Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, Silva AG, Brustolim D, Genser B, Dos Santos RR, Lyra LG. 2010; Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 22:33–42. DOI: 10.1097/MEG.0b013e32832eb69a. PMID: 19654548.

73. Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, Srinivas G, Raj TA, Tiwari SK, Kumaresan K, Venkateswarlu J, Pande G, Habibullah CM. 2010; Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant. 19:409–418. DOI: 10.3727/096368909X484707a. PMID: 20447340.

74. Nikeghbalian S, Pournasr B, Aghdami N, Rasekhi A, Geramizadeh B, Hosseini Asl SM, Ramzi M, Kakaei F, Namiri M, Malekzadeh R, Vosough Dizaj A, Malek-Hosseini SA, Baharvand H. 2011; Autologous transplantation of bone marrow-derived mononuclear and CD133(＋) cells in patients with decompensated cirrhosis. Arch Iran Med. 14:12–17. PMID: 21194255.

75. Saito T, Okumoto K, Haga H, Nishise Y, Ishii R, Sato C, Watanabe H, Okada A, Ikeda M, Togashi H, Ishikawa T, Terai S, Sakaida I, Kawata S. 2011; Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 20:1503–1510. DOI: 10.1089/scd.2011.0074. PMID: 21417817.

76. Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, Hegazy M. 2011; Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 23:936–941. DOI: 10.1097/MEG.0b013e3283488b00. PMID: 21900788.

77. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK. 2012; Granulocyte colony-stimulating factor mobilizes CD34(＋) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 142:505–512.e1. DOI: 10.1053/j.gastro.2011.11.027. PMID: 22119930.

78. Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL, Breguet R, Lanthier N, Farina A, Passweg J, Becker CD, Hadengue A. 2013; Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One. 8:e53719. DOI: 10.1371/journal.pone.0053719. PMID: 23341981. PMCID: PMC3544843.

79. Andreone P, Catani L, Margini C, Brodosi L, Lorenzini S, Sollazzo D, Nicolini B, Giordano R, Montemurro T, Rizzi S, Dan E, Giudice V, Viganò M, Casadei A, Foschi FG, Malvi D, Bernardi M, Conti F, Lemoli RM. 2015; Reinfusion of highly purified CD133＋ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial. Dig Liver Dis. 47:1059–1066. DOI: 10.1016/j.dld.2015.08.018. PMID: 26427587.

80. King A, Barton D, Beard HA, Than N, Moore J, Corbett C, Thomas J, Guo K, Guha I, Hollyman D, Stocken D, Yap C, Fox R, Forbes SJ, Newsome PN. 2015; Repeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133＋ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. BMJ Open. 5:e007700. DOI: 10.1136/bmjopen-2015-007700. PMID: 25795699. PMCID: PMC4368910.

81. Sharma M, Rao PN, Sasikala M, Kuncharam MR, Reddy C, Gokak V, Raju B, Singh JR, Nag P, Nageshwar Reddy D. 2015; Autologous mobilized peripheral blood CD34(＋) cell infusion in non-viral decompensated liver cirrhosis. World J Gastroenterol. 21:7264–7271. DOI: 10.3748/wjg.v21.i23.7264. PMID: 26109814. PMCID: PMC4476889.

82. Mohamadnejad M, Vosough M, Moossavi S, Nikfam S, Mardpour S, Akhlaghpoor S, Ashrafi M, Azimian V, Jarughi N, Hosseini SE, Moeininia F, Bagheri M, Sharafkhah M, Aghdami N, Malekzadeh R, Baharvand H. 2016; Intraportal infusion of bone marrow mononuclear or CD133＋ cells in patients with decompensated cirrhosis: a double-blind randomized controlled trial. Stem Cells Transl Med. 5:87–94. DOI: 10.5966/sctm.2015-0004. PMID: 26659833. PMCID: PMC4704869.

83. Yu SJ, Yoon JH, Kim W, Lee JM, Lee YB, Cho Y, Lee DH, Lee M, Yoo JJ, Cho EJ, Lee JH, Kim YJ, Kim CY. 2017; Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis. Korean J Intern Med. 32:261–268. DOI: 10.3904/kjim.2015.267. PMID: 27044856. PMCID: PMC5339463.